Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Augurex Life Sciences Corp. Names Healthcare Leader Neil Klompas to Succeed Co-Founder Dr. Norma Biln as President and CEO
-
D3 to Introduce “Ace AI”, with AI-Generated Playbooks, at Black Hat USA 2024
-
N-able Cloud Commander Now Offers Enhanced Windows 365 Management Capabilities
-
Kinaxis Spices Up Supply Chain Resilience for CMI Foods
-
PlanSource Welcomes Jennifer Zador as General Counsel and Chief Compliance Officer
-
Symbiotic Capital, a First-of-its-Kind Life Science Credit Firm, Launches with More than $600 Million Raised
-
JMI Equity Announces Promotions
-
OKYO Pharma Granted European Patent Covering OK-101 Chemerin Analogs and Their Method of Use
-
Beamr in Q2-2024: Enhancements to Beamr Cloud and Collaborations with Industry Giants
-
LeddarTech Enters Into Amendment to Credit Facility and Announces Receipt of Nasdaq Deficiency Notices
-
Rhythm Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Update
-
The National Minority Enterprise Development Week (MED Week) Deadline for Nominations Fast Approaching on August 15, 2024
-
ProMIS Neurosciences Announces Data on the Pathogenic Role of Toxic Misfolded SOD1 Aggregates in ALS Published in Acta Neuropathologica and Open Biology
-
Silvaco To Present at the Rosenblatt 4th Annual Technology Summit
-
European Wax Center Announces Appointment of Julia Hunter to Board Of Directors
-
Passage Bio to Participate in Upcoming Investor Conferences
-
GlobalFoundries Reports Second Quarter 2024 Financial Results
-
REMINDER: Stella-Jones Will Hold a Conference Call to Discuss Its Second-Quarter Results
-
Fuller Theological Seminary Announces the Launch of "The New Testament in Color"
-
Creative Realities Elevates Game Day with Innovative Digital Signage in Sports & Entertainment Venues
-
SimiTree Welcomes New Industry Experts Colleen Lazar and Brittney Lovely
-
George Medicines files New Drug Application with FDA for novel low dose triple combination for treatment of hypertension following successful international Phase III development program
-
EDAP’s Focal One Robotic HIFU Platform to be Featured at 41st World Congress of Endourology and Uro-Technology Meeting (WCET 2024)
-
AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
-
Novanta Announces Financial Results for the Second Quarter 2024
-
Viatris Announces Second Quarter 2024 Dividend
-
Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Garmin enables premium app purchases in the Connect IQ Store and unveils fun new watch faces and apps
-
Dotmatics Announces Investment in BioGlyph for Designing, Registering, and Modeling Multispecific Antibodies
-
Uber Announces Results for Second Quarter 2024
-
Bloomin’ Brands Announces 2024 Q2 Financial Results
-
USA Compression Partners Reports Second-Quarter 2024 Results; Updates 2024 Outlook; Achieves Record Revenue-generating Horsepower and Financial Results
-
Trimble Announces Second Quarter 2024 Results
-
Green Plains Reports Second Quarter 2024 Financial Results
-
Rand Capital Reports 18% Increase in Total Investment Income for Second Quarter 2024
-
Hyatt Reports Second Quarter 2024 Results
-
YieldMax™ ETFs Announces Monthly Distributions on MSTY (95.14%), TSLY (83.44%), CONY (75.83%), NVDY (64.52%), CRSH (61.10%) and Others
-
Salazar Welcomes New Partner Silvercorp Metals
-
Energizer Holdings, Inc. Announces Fiscal 2024 Third Quarter Results
-
Adient reports Q3 financial results; provides update to FY24 outlook
-
ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance
-
Invesco Ltd: Form 8.3 - DS Smith PLC
-
Constellation Reports Second Quarter 2024 Results
-
OLAPLEX Reports Second Quarter 2024 Results
-
MPLX LP Reports Second-Quarter 2024 Financial Results
-
Mallinckrodt plc Reports Second Quarter 2024 Financial Results and Raises Full Year Guidance
-
Kenvue Reports Second Quarter 2024 Results
-
TopBuild Reports Second Quarter Results
-
SOPHiA GENETICS Reports Second Quarter 2024 Results
-
Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070
